Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited) (USD $)	Exercise Agreement [Member] Additional Paid-in Capital [Member] USD ($)	Exercise Agreement [Member] USD ($)	Offer to Exercise [Member] Additional Paid-in Capital [Member] USD ($)	Offer to Exercise [Member] USD ($)	Preferred Stock [Member]	Common Stock [Member] USD ($)	Additional Paid-in Capital [Member] USD ($)	Retained Earnings [Member] USD ($)	Total USD ($)
Beginning balance at Dec. 31, 2012						$ 8,300	$ 62,425,400	$ (68,865,900)
Beginning balance (in Shares) at Dec. 31, 2012					0	82,616,750
Employee stock option issuances (in Shares)						1,459,972
Exercise of warrants (in Shares)						10,222,500
Vesting of restricted stock awards (in Shares)						1,208,412
Stock-based compensation expense							617,000
Net loss								(2,850,200)	(2,850,200)
Accretion of compensation expense, net of forfeitures – consultant warrants							11,800
Issuance of new warrants	514,800		45,600
New warrants recorded as cost	(514,800)		(45,600)
Reclassification of warrants liability to equity from amendment of warrants							4,391,000
Reclassification of warrants liability to equity from exercise of warrants							385,900
Exercise of employee stock options						100	302,600
Exercise of warrants						900	2,614,400
Vesting of restricted stock awards						200
Total Stockholders’ Equity at Sep. 30, 2013						9,500	70,748,100	(71,716,100)	(958,500)
Ending balance (in Shares) at Sep. 30, 2013					0	95,507,634
Beginning balance at Dec. 31, 2013						9,800	71,697,300	(72,611,900)	(904,800)
Beginning balance (in Shares) at Dec. 31, 2013					0	98,510,622
Private placement of stock and warrants (in Shares)						11,299,999
Employee stock option issuances (in Shares)						256,818
Exercise of warrants (in Shares)						1,000,000
Vesting of restricted stock awards (in Shares)						1,131,782
Stock-based compensation expense							417,000
Company payment of employee taxes for stock-based compensation							(1,800)
Net loss								(2,603,500)	(2,603,500)
Private placement of common stock and warrants						1,200	3,388,800
Cost of private placement of common stock and warrants							(20,000)
Allocation of proceeds from common stock and warrants to warrants liability							(1,356,000)
Accretion of compensation expense, net of forfeitures – consultant warrants							(3,600)
Issuance of new warrants		(514,800)		(45,600)
Exercise of employee stock options							47,800
Exercise of warrants						100	259,800
Vesting of restricted stock awards						100
Total Stockholders’ Equity at Sep. 30, 2014						$ 11,200	$ 74,429,300	$ (75,215,400)	$ (774,900)
Ending balance (in Shares) at Sep. 30, 2014					0	112,199,221